Company intelligence / Profile preview

MoBiTec

Göttingen, Lower Saxony, Germany

Ownership: Private
Employees: ~13
Development stage: Other

Overview

MoBiTec is a commercial-stage life science company specializing in molecular and cell biology research tools. It provides proprietary protein expression systems, purification columns, and a wide range of reagents. Following its acquisition by Calibre Scientific in 2024, it continues to operate as an integrated brand within BIOZOL Diagnostica.

Modalities: Recombinant proteinAntibodySmall molecule
Industry: Non-Drug Biotech

Partnerships

BIOZOLMirus BioAnaSpecABP BiosciencesION BiosciencesHansaBioMedCyagenDextra LaboratoriesEchelon Biosciences

Beyond the preview

Go deeper on MoBiTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MoBiTec.

Explore the full profile